Versor Investments’s Zimmer Biomet ZBH Stock Holding History

Versor Investments’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,460	Closed	-$316K	–	946
2025 Q2	$316K	Buy	+3,460	New	+$335K	0.06%	528
2024 Q4	–	Sell	-18,565	Closed	-$2M	–	1012
2024 Q3	$2M	Buy	18,565 +8,965	+93%	+$978K	0.32%	50
2024 Q2	$1.04M	Buy	+9,600	New	+$1.13M	0.19%	140
2023 Q2	–	Sell	-4,123	Closed	-$533K	–	865
2023 Q1	$533K	Buy	4,123 +1,223	+42%	+$154K	0.07%	307
2022 Q4	$370K	Buy	+2,900	New	+$337K	0.03%	434
2022 Q3	–	Sell	-9,724	Closed	-$1.02M	–	971
2022 Q2	$1.02M	Buy	+9,724	New	+$1.15M	0.04%	243
2022 Q1	–	Sell	-4,120	Closed	-$508K	–	716
2021 Q4	$508K	Buy	4,120 +206	+5%	+$27K	0.02%	260
2021 Q3	$556K	Buy	+3,914	New	+$576K	0.02%	237
2019 Q1	–	Sell	-2,266	Closed	-$228K	–	341
2018 Q4	$228K	Buy	+2,266	New	+$255K	0.05%	246

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Versor Investments's ZBH Position: Q3 2025 in Review

Versor Investments sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 3,460 shares — an estimated $316K sold.

Versor Investments first reported a position in ZBH in Q4 2018 and held it in 9 quarters. The position peaked at $2M in Q3 2024. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

Versor Investments reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
Versor Investments sold 3,460 Zimmer Biomet shares in Q3 2025, an estimated $316K.
Versor Investments first reported a position in Zimmer Biomet in Q4 2018 and held it in 9 quarters.
Versor Investments's Zimmer Biomet position peaked at $2M in Q3 2024.
966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Versor Investments's 13F filing for Q3 2025, filed 6 Nov 2025.